36.17
Xoma Royalty Corp Aktie (XOMA) Neueste Nachrichten
Earnings visualization tools for XOMA Royalty Corporation2025 Trading Recap & Daily Profit Maximizing Tips - newser.com
Is XOMA Royalty Corporation stock bottoming outJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - newser.com
What insider trading reveals about XOMA Royalty Corporation stockWeekly Volume Report & Verified Stock Trade Ideas - newser.com
Top chart patterns to watch in XOMA Royalty CorporationShort Setup & Daily Oversold Stock Bounce Ideas - newser.com
Short interest data insights for XOMA Royalty CorporationWeekly Trend Summary & Stock Portfolio Risk Management - newser.com
Is now a turning point for XOMA Royalty CorporationWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Weiss Ratings Reiterates "Sell (D-)" Rating for XOMA Royalty (NASDAQ:XOMA) - MarketBeat
XOMA Co. (NASDAQ:XOMAO) Short Interest Up 66.7% in September - Defense World
XOMA Royalty (NASDAQ:XOMA) Stock Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Strategies to average down on XOMA Royalty CorporationMarket Performance Report & Fast Moving Stock Watchlists - newser.com
Why XOMA Royalty Corporation (X0M1) stock attracts HNW investorsJuly 2025 Technicals & Entry Point Strategy Guides - newser.com
XOMA Royalty PFD Update: Going Back To My Original Sell Ratings (NASDAQ:XOMA) - Seeking Alpha
XOMA Royalty Corporation (NASDAQ:XOMA) On The Verge Of Breaking Even - simplywall.st
Is XOMA Royalty Corporation stock poised for growth2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
Will XOMA Royalty Corporation(X0M) stock outperform value peersTrend Reversal & Expert Verified Stock Movement Alerts - newser.com
Will XOMA Royalty Corporation (X0M1) stock profit from automation waveJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com
XOMA Royalty extends tender offer deadline for LAVA Therapeutics By Investing.com - Investing.com South Africa
XOMA Royalty extends tender offer deadline for LAVA Therapeutics - Investing.com
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. - The Manila Times
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. - Benzinga
75% CVR: XOMA Royalty Extends Tender Offer for LAVA, Extended to Oct. 17 - Stock Titan
Press Release: ESSA Pharma Inc. Amends Agreement With XenoTherapeutics - 富途牛牛
Press Release: XOMA Royalty Declares Quarterly Preferred Stock Dividends - 富途牛牛
Xoma announces closing of tender offer for HilleVax - MSN
What analysts say about XOMA Royalty CorporationX0M stockEx-Dividend Date Alerts & Analyze Your Portfolio Risk in Seconds - earlytimes.in
LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025 - Yahoo Finance
Is XOMA Royalty Corporation still worth holding after the dipJuly 2025 Analyst Calls & High Accuracy Trade Alerts - newser.com
Will XOMA Royalty Corporation (X0M1) stock hit analyst forecastsMarket Risk Summary & Entry Point Confirmation Alerts - newser.com
What makes XOMA Royalty Corporation stock attractive to growth fundsQuarterly Profit Summary & Long-Term Safe Investment Ideas - newser.com
Analyzing XOMA Royalty Corporation with multi timeframe charts2025 Institutional Moves & Fast Moving Market Watchlists - newser.com
Published on: 2025-09-29 02:44:30 - newser.com
XOMA Royalty Corporation stock momentum explained2025 Sector Review & Safe Capital Preservation Plans - newser.com
XOMA Royalty files correction to Series B preferred stock designation By Investing.com - Investing.com Nigeria
XOMA Royalty files correction to Series B preferred stock designation - Investing.com India
Why XOMA Royalty Corporation (X0M1) stock stays on buy listsJuly 2025 EndofMonth & Free Growth Oriented Trading Recommendations - newser.com
XOMA Royalty Declares Quarterly Preferred Stock Dividends - MSN
Essa Pharma Agrees to Amend Terms to Be Acquired by XenoTherapeutics - 富途牛牛
Xoma CFO Burns sells $155,820 in shares after option exercise By Investing.com - Investing.com South Africa
XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference - 富途牛牛
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics24.09.25News - Ariva
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):